LON:RTW RTW Biotech Opportunities (RTW) Share Price, News & Analysis GBX 1.32 +0.00 (+0.15%) As of 08/1/2025 11:16 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About RTW Biotech Opportunities Stock (LON:RTW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RTW alerts:Sign Up Key Stats Today's Range 1.30▼ 1.3250-Day Range 1.14▼ 1.3352-Week Range 1.08▼ 1.70Volume73,391 shsAverage Volume306,240 shsMarket Capitalization£443.41 millionP/E Ratio3.15Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies. Read More Receive RTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTW Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address RTW Stock News HeadlinesRTW Biotech Opportunities (LON:RTW) Trading Up 0.8% - What's Next?July 30 at 2:59 AM | americanbankingnews.comThe healthcare sector is unloved – this trust is a prime exampleJuly 17, 2025 | finance.yahoo.comDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.August 2 at 2:00 AM | American Alternative (Ad)RTWFF RTW Biotech Opportunities Ltd - Seeking AlphaJuly 1, 2025 | seekingalpha.comRTW Biotech hails Corxel obesity drug progress in US, China trialsJune 24, 2025 | lse.co.ukThis trust buys shares that can double in a day or be wiped out. The risk could be worth itJune 19, 2025 | finance.yahoo.comRTW Biotech investee sees encouraging results in cardiac disease trialMay 20, 2025 | lse.co.ukRTW Biotech Opportunities Ltd schedules June AGMMay 16, 2025 | investing.comSee More Headlines RTW Stock Analysis - Frequently Asked Questions How have RTW shares performed this year? RTW Biotech Opportunities' stock was trading at GBX 1.39 at the beginning of 2025. Since then, RTW shares have decreased by 5.0% and is now trading at GBX 1.32. How do I buy shares of RTW Biotech Opportunities? Shares of RTW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:RTW CIKN/A Webwww.rtwfunds.com Phone646-597-6980FaxN/AEmployees4,971Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.42 Trailing P/E Ratio3.15 Forward P/E RatioN/A P/E GrowthN/ANet Income£14.09 billion Net Margins664.38% Pretax MarginN/A Return on Equity25.18% Return on Assets-0.47% Debt Debt-to-Equity Ratio2.27 Current RatioN/A Quick Ratio0.81 Sales & Book Value Annual Sales£2.12 billion Price / Sales0.21 Cash FlowGBX 4.10 per share Price / Cash Flow0.32 Book ValueGBX 210.25 per share Price / Book0.01Miscellaneous Outstanding Shares33,591,400,000Free FloatN/AMarket Cap£443.41 million OptionableNot Optionable Beta0.60 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:RTW) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
